Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2026-01-13 @ 8:51 AM
Study NCT ID:
NCT05469828
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-30
First Post:
2021-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia
Sponsor:
Children's Hospital Los Angeles